Bruce S. Levison

22.2k total citations · 8 hit papers
46 papers, 12.6k citations indexed

About

Bruce S. Levison is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Bruce S. Levison has authored 46 papers receiving a total of 12.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 19 papers in Physiology and 5 papers in Organic Chemistry. Recurrent topics in Bruce S. Levison's work include Diet and metabolism studies (14 papers), Gut microbiota and health (14 papers) and Metabolomics and Mass Spectrometry Studies (8 papers). Bruce S. Levison is often cited by papers focused on Diet and metabolism studies (14 papers), Gut microbiota and health (14 papers) and Metabolomics and Mass Spectrometry Studies (8 papers). Bruce S. Levison collaborates with scholars based in United States, United Kingdom and Netherlands. Bruce S. Levison's co-authors include Stanley L. Hazen, Zeneng Wang, W.H. Wilson Tang, Yuping Wu, Xiaoming Fu, Robert Koeth, Earl B. Britt, Joseph A. DiDonato, Aldons J. Lusis and Jennifer A. Buffa and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Bruce S. Levison

46 papers receiving 12.4k citations

Hit Papers

Gut flora metabolism of phosphatidylcholine promotes card... 2011 2026 2016 2021 2011 2013 2015 2014 2014 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
    2011 4.1k citations Zeneng Wang, Brian J. Bennett et al. Nature profile →
  2. Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
    2013 2.4k citations W.H. Wilson Tang, Zeneng Wang et al. New England Journal of Medicine profile →
  3. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis
    2015 996 citations Zeneng Wang, Adam Roberts et al. Cell profile →
  4. Gut Microbiota-Dependent Trimethylamine N -Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney Disease
    2014 955 citations W.H. Wilson Tang, Zeneng Wang et al. profile →
  5. Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart Failure
    2014 536 citations W.H. Wilson Tang, Zeneng Wang et al. Journal of the American College of Cardiology profile →
  6. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide
    2014 458 citations W.H. Wilson Tang, Jennifer A. Buffa et al. European Heart Journal profile →
  7. γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO
    2014 424 citations Robert Koeth, Bruce S. Levison et al. Cell Metabolism profile →
  8. Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women
    2018 348 citations Zeneng Wang, Bruce S. Levison et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce S. Levison United States 29 8.6k 5.7k 2.0k 1.2k 1.1k 46 12.6k
Xiaoming Fu United States 32 8.1k 0.9× 5.5k 1.0× 1.7k 0.8× 1.5k 1.3× 1.1k 1.1× 76 13.9k
Yuping Wu United States 37 9.0k 1.1× 6.0k 1.0× 2.1k 1.1× 1.4k 1.2× 2.0k 1.9× 91 14.6k
Robert Koeth United States 10 5.6k 0.7× 3.7k 0.6× 1.4k 0.7× 845 0.7× 612 0.6× 15 8.3k
Brian J. Bennett United States 37 6.3k 0.7× 4.1k 0.7× 1.1k 0.6× 929 0.8× 655 0.6× 104 10.6k
Zeneng Wang United States 55 13.8k 1.6× 9.3k 1.6× 3.1k 1.6× 2.1k 1.8× 1.9k 1.8× 136 20.9k
Hooman Allayee United States 50 5.5k 0.6× 3.7k 0.6× 1.1k 0.6× 1.7k 1.4× 1.2k 1.1× 150 12.0k
Earl B. Britt United States 4 4.8k 0.6× 3.1k 0.5× 1.1k 0.6× 743 0.6× 503 0.5× 4 7.0k
Jennifer A. Buffa United States 20 4.0k 0.5× 2.6k 0.5× 747 0.4× 592 0.5× 477 0.5× 31 5.8k
Albert K. Groen Netherlands 79 12.9k 1.5× 6.5k 1.1× 944 0.5× 4.3k 3.6× 1.1k 1.0× 382 25.1k
Marcus Ståhlman Sweden 45 5.7k 0.7× 3.0k 0.5× 335 0.2× 1.9k 1.6× 481 0.5× 108 9.2k

Countries citing papers authored by Bruce S. Levison

Since Specialization
Citations

This map shows the geographic impact of Bruce S. Levison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce S. Levison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce S. Levison more than expected).

Fields of papers citing papers by Bruce S. Levison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce S. Levison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce S. Levison. The network helps show where Bruce S. Levison may publish in the future.

Co-authorship network of co-authors of Bruce S. Levison

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce S. Levison. A scholar is included among the top collaborators of Bruce S. Levison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce S. Levison. Bruce S. Levison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrell, Marc, Peter Bazeley, Zeneng Wang, et al.. (2021). Fecal Microbiome Composition Does Not Predict Diet‐Induced TMAO Production in Healthy Adults. Journal of the American Heart Association. 10(21). e021934–e021934. 22 indexed citations
2.
Zamanian-Daryoush, Maryam, Valentin Gogonea, Anthony J. DiDonato, et al.. (2020). Site-specific 5-hydroxytryptophan incorporation into apolipoprotein A-I impairs cholesterol efflux activity and high-density lipoprotein biogenesis. Journal of Biological Chemistry. 295(15). 4836–4848. 16 indexed citations
3.
Koeth, Robert, Miranda K. Culley, Zeneng Wang, et al.. (2019). CROTONOBETAINE IS A PROATHEROGENIC GUT MICROBIOTA METABOLITE OF L-CARNITINE. Journal of the American College of Cardiology. 73(9). 14–14. 3 indexed citations
4.
Lad, Apurva, Bruce S. Levison, David J. Kennedy, et al.. (2018). Development and applications of solid-phase extraction and liquid chromatography-mass spectrometry methods for quantification of microcystins in urine, plasma, and serum. Journal of Chromatography A. 1573. 66–77. 30 indexed citations
5.
Obrenovich, Mark E., et al.. (2017). Recent findings within the microbiota–gut–brain–endocrine metabolic interactome. Volume 9. 21–30. 16 indexed citations
6.
Senthong, Vichai, Xinmin S. Li, Timothy Hudec, et al.. (2016). Plasma Trimethylamine N -Oxide, a Gut Microbe–Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden. Journal of the American College of Cardiology. 67(22). 2620–2628. 187 indexed citations
7.
Wang, Zeneng, Adam Roberts, Jennifer A. Buffa, et al.. (2015). Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis. Cell. 163(7). 1585–1595. 996 indexed citations breakdown →
8.
Gu, Xiaodong, Ying Huang, Bruce S. Levison, et al.. (2015). Identification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein Interaction. Journal of Biological Chemistry. 291(4). 1890–1904. 26 indexed citations
9.
Tang, W.H. Wilson, Jennifer A. Buffa, Xiaoming Fu, et al.. (2014). Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. European Heart Journal. 35(14). 904–910. 458 indexed citations breakdown →
10.
Koeth, Robert, Bruce S. Levison, Miranda K. Culley, et al.. (2014). γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO. Cell Metabolism. 20(5). 799–812. 424 indexed citations breakdown →
11.
Tang, W.H. Wilson, Zeneng Wang, Bruce S. Levison, et al.. (2013). Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk. New England Journal of Medicine. 368(17). 1575–1584. 2425 indexed citations breakdown →
12.
Tang, Wenjie, et al.. (2013). Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk. Journal of Vascular Surgery. 58(2). 549–549. 46 indexed citations
13.
Wang, Zeneng, Brian J. Bennett, Robert Koeth, et al.. (2011). Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 472(7341). 57–63. 4126 indexed citations breakdown →
14.
Tang, W.H. Wilson, Wilson Tong, Kevin Shrestha, et al.. (2008). Differential effects of arginine methylation on diastolic dysfunction and disease progression in patients with chronic systolic heart failure. European Heart Journal. 29(20). 2506–2513. 90 indexed citations
15.
Gao, Shengqiang, Renliang Zhang, Michael E. Greenberg, et al.. (2006). Phospholipid Hydroxyalkenals, a Subset of Recently Discovered Endogenous CD36 Ligands, Spontaneously Generate Novel Furan-containing Phospholipids Lacking CD36 Binding Activityin Vivo. Journal of Biological Chemistry. 281(42). 31298–31308. 29 indexed citations
16.
Anning, Peter B., Barbara Coles, Alexandra Bermúdez-Fajardo, et al.. (2005). Elevated Endothelial Nitric Oxide Bioactivity and Resistance to Angiotensin-Dependent Hypertension in 12/15-Lipoxygenase Knockout Mice. American Journal Of Pathology. 166(3). 653–662. 45 indexed citations
17.
Nicholls, Stephen J., Zhongzhou Shen, Xiaoming Fu, Bruce S. Levison, & Stanley L. Hazen. (2005). Quantification of 3‐Nitrotyrosine Levels Using a Benchtop Ion Trap Mass Spectrometry Method. Methods in enzymology on CD-ROM/Methods in enzymology. 396. 245–266. 23 indexed citations
18.
Smiley, Jeffrey A., et al.. (2001). A Reexamination of the Substrate Utilization of 2-Thioorotidine-5′-monophosphate by Yeast Orotidine-5′-Monophosphate Decarboxylase. Bioorganic Chemistry. 29(2). 96–106. 10 indexed citations
19.
Levison, Bruce S., et al.. (1989). Ethoxyformylation of tubulin with [3H]diethyl pyrocarbonate: a reexamination of the mechanism of assembly inhibition. Biochemistry. 28(22). 8877–8884. 4 indexed citations
20.
Foreman, Darhl, Bruce S. Levison, Donald B. Miller, & Robert G. Salomon. (1988). Anhydrolevuglandin D2 inhibits the uterotonic acivity of prostaglandins F2α and D2. Prostaglandins. 35(1). 115–122. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoming Fu Breakdown of academic impact, for papers by Yuping Wu Breakdown of academic impact, for papers by Robert Koeth Breakdown of academic impact, for papers by Brian J. Bennett Breakdown of academic impact, for papers by Zeneng Wang Breakdown of academic impact, for papers by Hooman Allayee Breakdown of academic impact, for papers by Earl B. Britt Breakdown of academic impact, for papers by Jennifer A. Buffa Breakdown of academic impact, for papers by Albert K. Groen Breakdown of academic impact, for papers by Marcus Ståhlman
Rankless by CCL
2026